We describe utilization of procedures to reveal recent epidemiologic trends in evaluation and management of benign prostatic hyperplasia (BPH).
Medicare claims data reflect clinical practice in the vast majority of elderly Americans.
The standard 5% beneficiary sample from Medicare claims files for 1991 to 1995 was searched to identify men 65 years old or older with invoices containing diagnostic and procedure codes indicative of prostate disease or lower urinary tract symptoms.
Physician/supplier file claims for this sample of patients were used to identify diagnostic and therapeutic procedures relevant to BPH.
During these 5 years claims for uroflowmetry peaked in 1993, filling cystometry gradually declined and pressure flow studies increased.
Transurethral resection of the prostate decreased 43%, with even steeper reductions for open prostatectomy.
The proportion of transurethral resections performed in hospital inpatients ebbed from 96 to 88%. Age specific operative rates for transurethral resection were highest in the ninth decade, and during the 5 years operative rates generally declined more among white than black men of the same age. (...)
Mots-clés Pascal : Adénome, Prostate, Hyperplasie, Diagnostic, Symptomatologie, Echelle évaluation, Traitement, Evolution, Vieillard, Homme, Appareil urinaire pathologie, Appareil génital mâle pathologie, Prostate pathologie, Tumeur bénigne
Mots-clés Pascal anglais : Adenoma, Prostate, Hyperplasia, Diagnosis, Symptomatology, Evaluation scale, Treatment, Evolution, Elderly, Human, Urinary system disease, Male genital diseases, Prostate disease, Benign neoplasm
Notice produite par :
Inist-CNRS - Institut de l'Information Scientifique et Technique
Cote : 98-0420440
Code Inist : 002B30A01A2. Création : 25/01/1999.